The SLCO1A2 gene makes a transport protein that moves certain hormones, bile-related substances, and medicines into cells, especially in the gut and other barrier tissues. If this transporter works less well, your body may absorb or handle some drugs differently. This gene helps your body control how much of certain medicines reaches the bloodstream and tissues. Because of that, some variants in the SLCO1A2 gene can influence drug response rather than causing a single inherited condition.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate activities in the body. Some genes hold the directions for producing proteins, which are the functional parts of cells. Other genes mainly determine when certain processes happen, where they take place, and how strongly they occur. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
SLCO1A2Gene function
What if the gene works
The SLCO1A2 gene helps make a transport protein that moves certain hormones, bile salts, and some medicines into cells. This supports normal absorption and handling of substances in tissues such as the gut and brain.
Risk
What if the gene does not work
Milder to more severe variants in the SLCO1A2 gene can reduce or alter transport of certain molecules across cell membranes, especially in the intestine and other tissues. This changes how efficiently cells take up these compounds.
Treatment
What does that mean for your treatment
No SLCO1A2-specific treatment or management approach is currently established in clinical guidelines for people with pathogenic or loss-of-function variants in the SLCO1A2 gene. The SLCO1A2 gene is being studied as a drug response biomarker because changes in this transporter may alter how some medicines are absorbed or reach certain tissues, but this has not led to routine treatment changes.
Gene function
What if the gene works
Your cells rely on the SLCO1A2 gene to move certain body chemicals and some medicines from outside the cell to inside it. This transport supports everyday tasks such as absorption, distribution, and clearing substances from the body. Understanding what the SLCO1A2 gene does in the body helps explain how cells handle important compounds in a controlled way.
The SLCO1A2 gene helps cells pull selected compounds across their outer membrane. This gives cells access to substances they need to use, process, or move along.
Its transport protein carries several naturally made substances, including bile related compounds, thyroid hormones, and some steroid byproducts. This helps tissues handle these compounds as part of normal body chemistry.
In tissues such as the intestine and protective body barriers, this gene supports the controlled uptake of compounds from the surrounding fluid into cells. That movement helps determine where substances go in the body.
The same transport system can also bring certain medicines into cells. This is part of how the body absorbs and distributes some treatments under usual conditions.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help make up normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some cases, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
SLCO1A2 gene variants can change the shape, stability, or cell surface placement of the transporter protein, which may reduce how well it moves substances into cells. Some changes are mild and only partly lower activity, while more disruptive variants can shorten the protein, alter RNA splicing (how the gene message is cut and joined), or prevent the protein from working at all. The size of this functional change can vary from one variant to another.
How variants are linked to conditions
Research on SLCO1A2 variants linked to conditions is still developing, and this gene does not yet have a broadly confirmed link to a specific health condition. If you have a confirmed SLCO1A2-related diagnosis, your doctor or genetic counselor can explain what that result means for you and your family.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply contribute to natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a definite diagnosis, especially when several genes and environmental influences play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SLCO1A2 gene itself. Changes in this gene are more often discussed for how some medicines are absorbed and handled in the body than for a clear, single disease risk. Anyone concerned about personal risk should speak with a doctor or genetic counselor.
Inheritance of SLCO1A2 variants
There is not yet a broadly confirmed Mendelian pattern for how SLCO1A2 gene variants are inherited in relation to a specific SLCO1A2 related condition. In practice, how variants of the SLCO1A2 gene are inherited follows the usual pattern for a gene on chromosome 12: you inherit one copy from your mother and one copy from your father. Because SLCO1A2 is on an autosome rather than a sex chromosome, inheritance is generally similar in males and females.
What does my SLCO1A2 result mean for my family?
There is not yet a broadly confirmed family inheritance pattern tied to a specific health condition for SLCO1A2, though this can change as research develops. If you have a specific SLCO1A2 result, its meaning for relatives depends on exactly what was found and why the testing was done.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the SLCO1A2 gene usually uses a blood sample or cheek swab to read the DNA sequence of this gene. It can show whether you carry a specific variant, often as part of a pharmacogenetic panel (a test that looks at genes that can affect how your body handles medicines).
When should I consider getting a genetic test?
At this time, there is not a widely established medical reason to order a genetic test for the SLCO1A2 gene on its own. Testing decisions are usually based on your overall health history, family history, and guidance from a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it explains depends on the condition and the kind of variant present. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most meaningful when considered with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results may help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in how the body absorbs, moves, and clears a drug can change how much of it reaches the bloodstream or target tissues, so the same treatment may work better for some people and cause more side effects in others. This kind of variation is common and helps explain why medication response can differ from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect a person’s response to medications. It studies gene and drug patterns to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body processes it. This information can support more informed and individualized treatment decisions. To explore this topic further, you can learn more in the LearnHub.
Drugs influenced by the SLCO1A2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in routine medication decisions, so general concerns about side effects, drug response, or new medicines are best discussed with your doctor. SLCO1A2 has been studied for how the body absorbs some medicines, including certain allergy medicines and cancer treatments, but this research is not used routinely in everyday care.
History
SLCO1A2 entered the scientific literature in the late 1990s, when researchers were mapping a growing family of transport genes in human tissues. Initially understood only through visible traits, later recognized as tied to a specific gene, this area of research helped organize several related transporters under the OATP naming system. Early studies described SLCO1A2 under older names such as OATP-A before gene naming became more standardized. From these first observations, research expanded steadily as scientists compared where the gene was active and how it related to drug handling in the body. Over time, descriptions became more precise, and SLCO1A2 found its place within the broader history of pharmacogenetics and transporter biology.